|
Volumn 119, Issue 1 SUPPL., 2001, Pages 207S-219S
|
Antithrombotic therapy in valvular heart disease
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTIINFLAMMATORY AGENT;
CLOPIDOGREL;
DIPYRIDAMOLE;
HEPARIN;
SULFINPYRAZONE;
TICLOPIDINE;
WARFARIN;
AGE;
ANTICOAGULANT THERAPY;
AORTA VALVE DISEASE;
ARTERY CALCIFICATION;
BACTERIAL ENDOCARDITIS;
BLEEDING;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DISEASE ASSOCIATION;
DRUG WITHDRAWAL;
HEART ATRIUM SEPTUM DEFECT;
HUMAN;
LIFESTYLE;
LONG TERM CARE;
MITRAL VALVE PROLAPSE;
MITRAL VALVE REGURGITATION;
MITRAL VALVE STENOSIS;
PATHOGENESIS;
PATIENT ATTITUDE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RHEUMATIC HEART DISEASE;
RISK FACTOR;
THROMBOEMBOLISM;
TREATMENT OUTCOME;
VALVULAR HEART DISEASE;
|
EID: 0035128419
PISSN: 00123692
EISSN: None
Source Type: Journal
DOI: 10.1378/chest.119.1_suppl.207S Document Type: Conference Paper |
Times cited : (62)
|
References (150)
|